Lobular Breast Cancer Alliance (LBCA) is proud to celebrate two members of our team who were recently named to OncoDaily’s 100 Most Influential Cancer Survivors of 2026.

Laurie Hutcheson, Invasive Lobular Carcinoma (ILC) Patient Advocate & Executive Director and Gitte Henssel Joergensen, Research Associate were recognized for their leadership, advocacy, and contributions to the cancer community. Through their dedication to advancing awareness of ILC, supporting research, and empowering patients, Laurie and Gitte embody LBCA’s mission to improve outcomes for everyone affected by ILC.

Their recognition reflects the vital role of patient advocates in raising awareness of the unique characteristics of ILC, advancing research, and fostering collaboration among patients, researchers, and clinicians.